Literature DB >> 9581007

The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration.

L de la Fuente1, G Barrio, L Royuela, M J Bravo.   

Abstract

AIMS: To measure the current prevalence of different routes of heroin administration among users and to describe the most frequent patterns in the evolution of the main route from the time of first use to the present and their implications for the control of the HIV epidemic.
DESIGN: Cross-sectional study. Face-to-face interviews using a structured questionnaire. SETTING AND PARTICIPANTS: Nine hundred and nine regular heroin users from Madrid, Barcelona and Seville (about 300 per city), half of them recruited in treatment centres and the other half out of treatment. MEASUREMENTS: Socio-demographic characteristics, current and historical behaviours related to route of administration.
FINDINGS: Before 1980 injection was the first main route of heroin administration for most users in Barcelona and Madrid; in Seville smoking already predominated, although 40% of users began by injecting. Sniffing subsequently became predominant in Barcelona, while smoking became the predominant first route in Madrid and Seville (smoking has been the only first route in Seville since 1991). The prevalence of injection as the main route of administration during the last 30 days was 77.3% in Barcelona, 24.3% in Madrid and 23.9% in Seville; smoking predominated in the latter two cities. The factors most strongly associated with injection as the preferred route were city of recruitment and having a partner who injected. Some 73% of those who stopped injecting in their last change of route stated that the results of their HIV test or fear of becoming infected had been important in making this decision.
CONCLUSIONS: The change from injecting to smoking will greatly facilitate the control of HIV infection in Spain. However, the main causal factor does not appear to be the perception of HIV risk, but rather other, ecological factors (cultural or market-related). The absence of these factors in some areas may impede the spread of smoking.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9581007

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  14 in total

1.  Characteristics of heroin and cocaine users unknown to treatment agencies. Results from the Swiss Hidden Population Study.

Authors:  D Hausser; D Kübler; F Dubois-Arber
Journal:  Soz Praventivmed       Date:  1999

2.  Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions.

Authors:  E J van Ameijden; R A Coutinho
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

3.  Cessation of injecting drug use among street-based youth.

Authors:  Colin Steensma; Jean-François Boivin; Lucie Blais; Elise Roy
Journal:  J Urban Health       Date:  2005-09-29       Impact factor: 3.671

4.  Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

Authors:  Luis de la Fuente; María José Bravo; Carlos Toro; M Teresa Brugal; Gregorio Barrio; Vicente Soriano; Fernando Vallejo; Rosario Ballesta
Journal:  J Epidemiol Community Health       Date:  2006-06       Impact factor: 3.710

5.  Potential risk factors for injecting among Mexican American non-injecting heroin users.

Authors:  Avelardo Valdez; Alan Neaigus; Alice Cepeda
Journal:  J Ethn Subst Abuse       Date:  2007       Impact factor: 1.507

6.  Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose?

Authors:  Montserrat Neira-León; Gregorio Barrio; M Teresa Brugal; Luis de la Fuente; Rosario Ballesta; María J Bravo; Teresa C Silva; Alicia Rodríguez-Martos
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

7.  The growing popularity of prescription opioid injection in downtown Montréal: new challenges for harm reduction.

Authors:  Elise Roy; Nelson Arruda; Phillipe Bourgois
Journal:  Subst Use Misuse       Date:  2011-03-03       Impact factor: 2.164

8.  Can intranasal drug use reduce HCV infection among injecting drug users?

Authors:  Don C Des Jarlais; Holly Hagan; Kamyar Arasteh; Courtney McKnight; Salaam Semaan; David C Perlman
Journal:  Drug Alcohol Depend       Date:  2011-07-26       Impact factor: 4.492

9.  Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.

Authors:  G Barrio; L De La Fuente; C Toro; T M Brugal; V Soriano; F Gonzalez; M J Bravo; F Vallejo; T C Silva
Journal:  Epidemiol Infect       Date:  2006-09-28       Impact factor: 2.451

10.  Pattern of buprenorphine abuse among opioid abusers in Nepal.

Authors:  Tapas Kumar Aich; Manoj Dhungana; Roshija Khanal
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.